Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.

Hetherington K, Hunter JD, Donoghoe MW, McGillycuddy M, McGill BC, Robertson EG, Tyrrell V, Lau LMS, Marron JM, Tucker KM, Marshall GM, Vetsch J, Haber M, Malkin D, Mateos MK, O'Brien TA, Ziegler DS, Wakefield CE.

Open source

DOI
10.1038/s41525-026-00591-y
Published
2026-07-03
Container
NPJ Genom Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41525-026-00591-y,
  title = {Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.},
  author = {Hetherington K and  Hunter JD and  Donoghoe MW and  McGillycuddy M and  McGill BC and  Robertson EG and  Tyrrell V and  Lau LMS and  Marron JM and  Tucker KM and  Marshall GM and  Vetsch J and  Haber M and  Malkin D and  Mateos MK and  O'Brien TA and  Ziegler DS and  Wakefield CE.},
  year = {2026},
  journal = {NPJ Genom Med},
  doi = {10.1038/s41525-026-00591-y},
  url = {https://doi.org/10.1038/s41525-026-00591-y}
}

RIS

TY  - JOUR
TI  - Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.
AU  - Hetherington K
AU  -  Hunter JD
AU  -  Donoghoe MW
AU  -  McGillycuddy M
AU  -  McGill BC
AU  -  Robertson EG
AU  -  Tyrrell V
AU  -  Lau LMS
AU  -  Marron JM
AU  -  Tucker KM
AU  -  Marshall GM
AU  -  Vetsch J
AU  -  Haber M
AU  -  Malkin D
AU  -  Mateos MK
AU  -  O'Brien TA
AU  -  Ziegler DS
AU  -  Wakefield CE.
PY  - 2026
JO  - NPJ Genom Med
DO  - 10.1038/s41525-026-00591-y
UR  - https://doi.org/10.1038/s41525-026-00591-y
ER  - 

APA

K, H., JD, H., MW, D., M, M., BC, M., EG, R., V, T., LMS, L., JM, M., KM, T., GM, M., J, V., M, H., D, M., MK, M., TA, O., DS, Z., & CE., W. (2026). Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.. NPJ Genom Med. https://doi.org/10.1038/s41525-026-00591-y

Source records